A Peek Into The Market Before The Trading Starts
Pre-open movers US stock futures are higher this morning. Futures for the Dow Jones Industrial Average gained 27 points to 13,952.00 and S&P 500 index futures rose 2.70 points to 1,515.10. Nasdaq 100 futures climbed 4.25 points to 2,776.25.
A Peek Into Global Markets European markets were mostly higher today. The STOXX Europe 600 Index fell 0.36%, London's FTSE 100 Index gained 0.32%, German DAX 30 Index rose 0.05% and French CAC 40 Index climbed 0.38%.
Asian markets ended mostly lower, with Australia's S&P/ASX 200 Index dropping 0.18% and India's Sensex falling 0.12%.
Broker Recommendation Analysts at Stifel Nicolaus upgraded U.S. Bancorp (NYSE: USB) from “sell” to “hold.” The target price for U.S. Bancorp is set to $39.
U.S. Bancorp shares gained 0.77% to $33.91in pre-market trading.
- AMRI (NASDAQ: AMRI) announced today that it has signed an exclusive license agreement with Chai Therapeutics, LLC for the development of ALB 109564(a), AMRI's novel tubulin inhibitor compound in late Phase I testing for the treatment of cancer. To read the full news, click here.
- Brookfield Asset Management (NYSE: BAM) today announced the acquisition of portfolio of 19 apartment communities with 4,892 units located in North Carolina, South Carolina and Virginia for a total of $414 million from Babcock & Brown Residential. To read the full news, click here.
- Science Applications International Corporation (SAIC) (NYSE: SAI) announced today it was awarded a prime contract by the United States Army to provide command, control, communications, computers, intelligence, surveillance and reconnaissance (C4ISR) rapid prototyping and technology insertion support to the Communications-Electronics Research Development & Engineering Center (CERDEC) Command, Power and Integration Directorate Prototyping, Integration and Testing Division. To read the full news, click here.
- Life Technologies (NASDAQ: LIFE) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore® HLA typing kits. To read the full news, click here.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.